Company intelligence / Profile preview

Genera Research Ltd.

Zagreb area, Croatiagenera-research.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Genera Research Ltd. develops recombinant human BMP-based products for tissue regeneration. Its lead candidate, OSTEOGROW using BMP6 in an autologous blood coagulum, has completed Phase II trials in orthopaedic indications and continues development in spinal fusion with European grant support. The company holds over 30 global patents related to its innovations.

Therapeutic areas: OtherRheumatologyNeurology
Modalities: Recombinant proteins (notably recombinant human Bone Morphogenetic Protein 6 - rhBMP6)
Industry: Biotech

Drug pipeline

5 assets

bone morphogenetic protein 6

Preclinical

4 more assets in the full pipeline.

Request access →

Partnerships

European Union FP7 and Horizon2020 grants for clinical research consortia involving academic and medical partners

Beyond the preview

Go deeper on Genera Research Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genera Research Ltd..

Explore the full profile